5 U.S. ETFs Seeing Fireworks Ahead Of July Fourth

The year so far has been a good one for the U.S. stock market amid bouts of woes and uncertainties. This is especially true as Wall Street logged in the strongest performance in decades in the first half of the year. The S&P 500 jumped 17% — its best first-half performance since 1997 — while the Dow climbed 14%, its best show since 1999. Meanwhile, the Nasdaq Composite Index skyrocketed more than 20%, recording its best first six months of the year since 2003.

Though trade war jitters, global growth concerns, recession fears, government shutdown, geopolitical tension, and weak corporate earnings weighed on stocks, the rally was powered by hopes of easing money policies. The Fed signaled rate cuts in the near term that led to renewed confidence in the slowing economy. Lower interest rates will keep borrowing cost down, thereby resulting in higher consumer spending and rise in economic activities. Additionally, recovery in the U.S. housing market, rising oil price and the wave of mergers & acquisitions added to the strength.

While there are winners in many corners of the space, a few have easily crushed the Wall Street returns. In fact, they have generated more than double the returns of the S&P 500. We have highlighted them that skyrocketed more than 30% in the year-to-date timeframe.

These funds focus exclusively on U.S. equities and deserve the attention of investors seeking a domestic tilt to their portfolio ahead of the Jul 4 holiday.

ARK Genomic Revolution Multi-Sector ETF (ARKG - Free Report)

The biotech sector has been on the mend amid ongoing industry consolidation and attractive valuations. Particularly, the surge in demand for artificial intelligence for the advancement of diagnoses and treatment across the health care spectrum has been driving this ETF. This is an actively managed ETF, focusing on companies likely to benefit from the extension and enhancement of the quality of human and other life by incorporating technological and scientific developments plus improvements and advancements in genomics into their business. With AUM of $448.4 million, the fund holds 37 stocks in its basket and has 0.75% in expense ratio. It trades in average daily volume of 149,000 shares and has soared 42% this year so far.

1 2 3
View single page >> |

Disclosure: Zacks.com contains statements and statistics that have been obtained from sources believed to be reliable but are not guaranteed as to accuracy or completeness. References to any specific ...

How did you like this article? Let us know so we can better customize your reading experience. Users' ratings are only visible to themselves.


Leave a comment to automatically be entered into our contest to win a free Echo Show.